ABSTRACTIn the pre-clinical evaluation of anti-cancer drugs, two different measurement approaches are used: relative viability, which scores an amalgam of growth arrest and cell death, and fractional viability, which more specifically scores the degree of cell killing. In this study, we directly quantify relationships between drug-induced growth inhibition and drug-induced cell death by counting live and dead cells over time using quantitative microscopy. We find that most drugs affect both growth and death, but with different proportions and with different relative timing. These features lead to a non-uniform and unpredictable relationship between the canonical relative and fractional drug response measurements. To unify these disparate measurements, we create a new data visualization and data analysis platform, called drug GRADE, which characterizes the degree to which cell death contributes to an observed reduction in population size for any given drug. Our new method reveals both drug- and genotype-specific drug responses, which are not captured using traditional pharmaco-metrics. Taken together, this study highlights the extremely idiosyncratic nature of drug-induced growth and cell death and provides a new analysis tool for quantitatively evaluating these behaviors.
Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response Profiles